Find clinical trials for Lymphoma in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near New York, NY, USA:
glofitamab and obinutuzumab is in treating patients with Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL) who have not rec...
Phase 2
New York, New York, United States and 3 other locations
in participants with relapsed/refractory (R/R) peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), follicular helper T-cell lymphomas...
Phase 3
New York, New York, United States and 16 other locations
This research is being done to see if epcoritamab is effective in treating follicular lymphoma as a second line of treatment.The name of the...
Phase 2
New York, New York, United States and 2 other locations
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
Hackensack, New Jersey, United States and 68 other locations
of MT-601 administration to patients with Relapsed or Refractory Lymphoma. The starting dose administered is 200 x 10\^6 cells (flat dosing)....
Phase 1
New York, New York, United States and 6 other locations
diagnosed or relapsed/refractory (for CTCL only) aggressive T-cell lymphoma including patients with Adult T-cell leukemia/lymphoma ...
Phase 2
New York, New York, United States and 1 other location
with or without Sonrotoclax in participants with Mantle Cell Lymphoma (MCL).The names of the study drugs involved in this study are:* bendam...
Phase 2
New York, New York, United States and 6 other locations
and ibrutinib in patients with previously treated mantle cell lymphoma to evaluate the efficacy of this combination, with the primary object...
Phase 2
New York, New York, United States and 8 other locations
is in treating participants with relapse or refractory Follicular Lymphoma (FL) or marginal zone lymphoma (MZL).* The names of the ...
Phase 2
New York, New York, United States and 2 other locations
chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma....
Phase 1, Phase 2
The Bronx, New York, United States and 26 other locations
Clinical trials
Research sites
Resources
Legal